Cencora (COR) Shares Outstanding (Diluted Average) (2009 - 2026)
Cencora (COR) reported Shares Outstanding (Diluted Average) of $195.4 million for Q1 2026, little changed on a YoY basis from $195.1 million in Q1 2025, and little changed quarter-over-quarter from $195.3 million in Q4 2025.
Cencora (COR) Shares Outstanding (Diluted Average) (2009 - 2026) Analysis & Trends
Cencora has reported Shares Outstanding (Diluted Average) for 18 years, with the latest figure at $195.4 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) changed 0.15% year-over-year to $195.4 million; the trailing twelve-month figure through Mar 2026 stood at $195.4 million (changed 0.15% YoY), and the FY2025 full-year result was $195.2 million, down 2.53% from the prior year.
- Shares Outstanding (Diluted Average) for Q1 2026 stood at $195.4 million, roughly flat from $195.3 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $212.0 million in Q1 2022, with the low at $195.1 million in Q1 2025.
- Historically, Shares Outstanding (Diluted Average) has averaged $201.8 million across 5 years, with a median of $201.2 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) gained 2.26% — and 2024, when it fell 3.29%.
- Cencora's Shares Outstanding (Diluted Average) stood at $206.3 million in 2022, then dropped by 2.18% to $201.8 million in 2023, then declined by 3.29% to $195.2 million in 2024, then advanced by 0.07% to $195.3 million in 2025, then gained by 0.03% to $195.4 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $195.4 million (Q1 2026), $195.3 million (Q4 2025), and $195.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 1.00 |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 124.10 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 195.38 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 236.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 116.06 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 37.48 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 24.54 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 47.09 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 14.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 195.38 Mn |
| Dec 31, 2025 | 195.32 Mn |
| Sep 30, 2025 | 195.21 Mn |
| Jun 30, 2025 | 195.23 Mn |
| Mar 31, 2025 | 195.09 Mn |
| Dec 31, 2024 | 195.19 Mn |
| Sep 30, 2024 | 200.28 Mn |
| Jun 30, 2024 | 200.05 Mn |
| Mar 31, 2024 | 201.18 Mn |
| Dec 31, 2023 | 201.84 Mn |
| Sep 30, 2023 | 204.59 Mn |
| Jun 30, 2023 | 205.00 Mn |
| Mar 31, 2023 | 205.31 Mn |
| Dec 31, 2022 | 206.33 Mn |
| Sep 30, 2022 | 211.21 Mn |
| Jun 30, 2022 | 211.74 Mn |
| Mar 31, 2022 | 211.99 Mn |
| Dec 31, 2021 | 211.17 Mn |
| Sep 30, 2021 | 208.47 Mn |
| Jun 30, 2021 | 208.91 Mn |